Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.

Piñero F, Marciano S, Fernández N, Silva J, Anders M, Zerega A, Ridruejo E, Romero G, Ameigeiras B, D'Amico C, Gaite L, Bermúdez C, Reggiardo V, Colombato L, Gadano A, Silva M.

World J Gastroenterol. 2019 Jul 21;25(27):3607-3618. doi: 10.3748/wjg.v25.i27.3607.

2.

Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma.

Piñero F, Mendizabal M, Ridruejo E, Herz Wolff F, Ameigeiras B, Anders M, Schinoni MI, Reggiardo V, Palazzo A, Videla M, Alonso C, Santos L, Varón A, Figueroa S, Vistarini C, Adrover R, Fernández N, Perez D, Tanno F, Hernández N, Sixto M, Borzi S, Bruno A, Cocozzella D, Soza A, Descalzi V, Estepo C, Zerega A, de Araujo A, Cheinquer H, Silva M; LALREAN.

Liver Int. 2019 Jun;39(6):1033-1043. doi: 10.1111/liv.14041. Epub 2019 Feb 4.

PMID:
30636361
3.

Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?

Piñero F, Rubinstein F, Marciano S, Fernández N, Silva J, Zambelo Y, Anders M, Zerega A, Ridruejo E, Miguez C, Ameigeiras B, D'Amico C, Gaite L, Bermúdez C, Rosales C, Romero G, McCormack L, Reggiardo V, Colombato L, Gadano A, Silva M.

Dig Dis Sci. 2019 Mar;64(3):718-728. doi: 10.1007/s10620-018-5390-z. Epub 2018 Dec 3.

PMID:
30511199
4.

Adherence to Barcelona Clinic Liver Cancer therapeutic algorithm for hepatocellular carcinoma in the daily practice: a multicenter cohort study from Argentina.

Piñero F, Marciano S, Fernández N, Silva J, Zambelo Y, Cobos M, Zerega A, Ridruejo E, Miguez C, Ameigeiras B, D'Amico C, Gaite L, Coronel M, Bermúdez C, Rosales C, Romero G, McCormack L, Reggiardo V, Colombato L, Gadano A, Rubinstein F, Silva M; Argentinean Association for the Study of Liver Diseases (A.A.E.E.H).

Eur J Gastroenterol Hepatol. 2018 Apr;30(4):376-383. doi: 10.1097/MEG.0000000000001049.

PMID:
29509603
5.

Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina.

Piñero F, Pages J, Marciano S, Fernández N, Silva J, Anders M, Zerega A, Ridruejo E, Ameigeiras B, D'Amico C, Gaite L, Bermúdez C, Cobos M, Rosales C, Romero G, McCormack L, Reggiardo V, Colombato L, Gadano A, Silva M.

World J Hepatol. 2018 Jan 27;10(1):41-50. doi: 10.4254/wjh.v10.i1.41.

6.

Strategic approach to produce low-cost, efficient, and stable competitive internal controls for detection of RNA viruses by use of reverse transcription-PCR.

Villanova GV, Gardiol D, Taborda MA, Reggiardo V, Tanno H, Rivadeneira ED, Perez GR, Giri AA.

J Clin Microbiol. 2007 Nov;45(11):3555-63. Epub 2007 Aug 15.

7.

Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial.

Vorobioff JD, Ferretti SE, Zangroniz P, Gamen M, Picabea E, Bessone FO, Reggiardo V, Diez AR, Tanno M, Cuesta C, Tanno HE.

Am J Gastroenterol. 2007 Oct;102(10):2206-13. Epub 2007 Jun 29.

PMID:
17608776
8.

[Treatment of patients with normal liver aminotransferases].

González Ballerga E, Levi D, Reggiardo V.

Acta Gastroenterol Latinoam. 2005 Jun;35 Suppl 1:S50-2. Spanish. No abstract available.

PMID:
20214303
9.

[Treatment of relapsers].

Galdame O, Manero E, Reggiardo V.

Acta Gastroenterol Latinoam. 2005 Jun;35 Suppl 1:S39-41. Spanish. No abstract available.

PMID:
20214298
10.

Prognostic significance of hepatic encephalopathy in patients with cirrhosis.

Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodés J.

J Hepatol. 1999 May;30(5):890-5.

PMID:
10365817

Supplemental Content

Loading ...
Support Center